Breast Cancer

To estimate 3-year and 5-year progression-free survival rate for the regimen. Eligibility Patients must be 18 year of age or older. Previous untreated Stage III, IV or bulky Stage II follicular B-cell Non-Hodgkin's lymphoma, positive for CD20. Bone marrow aspiration and biopsy must be performed. ................
................